Clinical Trial 2016-2778


A Phase IIA, Multi-Center, Randomized, Single-Blind, Placebo-Controlled, Crossover Study To Assess The Safety, Tolerability, And Preliminary Efficacy Of A Single Intravenous Dose of Allogeneic Human Mesenchymal Stem Cells To Subjects With Mild to Moderate Dementia Due to Alzheimer's Disease (Protocol: STEM105-M-AD Date: May 21, 2015)

Principal Investigator

Aimee Pierce


Learn More

For more information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email